Terpenes’ contribution to the therapeutic effect of cannabinoids “may be significant.”
A new study by researchers in Israel says people suffering depression and/or mood disorders may one day find relief in cannabis-based treatments that include terpenes – the aromatic oils that give cannabis its distinctive smell.
The study reviews the past 25 years of scientific research and adds to a growing body of knowledge about the potential efficacy of botanicals in the treatment of mental-health conditions.
THC combined with CBD may reduce depression and CBD appears to have “high potency in relieving…depression, anxiety and bipolar disorder,” said the researchers.
The research was published in Current Neuropharmacology, Sept/19.
Breast cancer may respond to a “botanical drug preparation” of cannabinoids and terpenes, said Spanish researchers in 2018.
In certain forms of breast cancer this treatment was “more potent that pure THC in producing anti-tumour responses” in both animals and cancer-cell cultures, they said.
American neurologist and cannabis-research pioneer Dr. Ethan Russo was among the first to propose “synergistic interactions” between cannabinoids and terpenes in: